Counterfeiting, Compliance, and Controls

FDA and manufacturers seek to curb drug counterfeiting while legislators consider liberalizing drug importing policies to cut pharmaceutical costs.

Related Content:

Regulatory WatchSupply ChainAnticounterfeiting, Track and Trace SystemsPharmaceutical Technology-09-02-2003

The Real Danger of Substandard and Counterfeit COVID-19 Vaccines

Changing the Course of Drug Shortages

AstraZeneca and European Commission Reach Settlement Agreement Over COVID-19 Vaccine Supply